Analysis

'Groundbreaking' AbbVie Suits Test Bold Anti-Generic Tactics

By Jeff Overley · March 27, 2019, 8:43 PM EDT

A trio of trailblazing antitrust lawsuits targeting AbbVie Inc. will force a day of reckoning for some of Big Pharma's most audacious and controversial maneuvers to delay generic and biosimilar competition,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Humira (Adalimumab) Antitrust Litigation

Case Number

1:19-cv-01873

Court

Illinois Northern

Nature of Suit

410(Anti-Trust)

Date Filed

March 18, 2019

Case Title

Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund v. AbbVie Inc. et al

Case Number

1:19-cv-01933

Court

Illinois Northern

Nature of Suit

410(Anti-Trust)

Date Filed

March 20, 2019

Case Title

Mayor and City Council of Baltimore v. AbbVie, Inc. et al

Case Number

1:19-cv-02015

Court

Illinois Northern

Nature of Suit

410(Anti-Trust)

Date Filed

March 22, 2019

Recent Articles By Jeff